Fritextsökning
Innehållstyper
-
Lovande i studie om bröstcancer
Läkemedelskandidaten fulvestrant, som utvecklas av Astrazeneca, visar positiva resultat i en fas II-studie.
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
Academy for a new turn at work
Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.
-
Köper mer
Karo Bio fortsätter på sin nya strategi och genomför årets femte förvärv.
-
Blottning i automatiserat system
iBlot Dry Blotting System från Invitrogen används tilsammans med engångskassetter och fungerar helt utan separata buffertar för att blotta proteiner på 7 minuter.
-
New member to Active board
The Election Committee of Active Biotech proposes a very experienced financial sector executive to join the company board. Five existing members are also to be ...
-
Swedish top scientists to EMBO
Two Swedish top scientists will have a really good chance to influence European life science research from now on. One is from the Karolinska Institutet, and on...
-
Kancera tar in pengar
Tankar kassan för finansiera sin läkemedelsutveckling och genomförandet av kliniska studier.
-
Orexo får projekt i retur
Utvecklingspartnern Boehringer Ingelheim lämnar tillbaka smärtprojektet OX-MPI.
-
Researchers goes to the bottom of the brain
Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.
-
Medivir startar hepatit-studie
Bolaget får 62 miljoner kronor i milstolpebetalning när fas Ia-studien med ett preparat för behandling av kronisk hepatit C-virusinfektion nu påbörjas.
-
How to get visitors to your booth
Food, ball throwing and laser engraved pens. There are many tricks to attract visitors to the stands at Scanlab.
-
Hennes tweet sänker börsen
Hillary Clinton föreslår nya tag mot skenande läkemedelspriser.
-
Skandal-vd avgår
Martin Shkreli avgår från posten som vd för Turing Pharmaceuticals efter gripandet förra veckan.
-
Pfizer överväger nya bud
Obama-administrationens nya skatteregler hämmar inte bolagets köplust.
-
Welcome to wonderful Copenhagen
Strategically located, the Danish capital is the focal point of one of the most dynamic regions in Northern Europe. Here are some tips on where to spend your ti...
-
Fat cells' reaction differs with body weight
The fat cells of overweight people may react differently to dietary changes than in their lean peers, according to a pioneering study from the Dutch organizatio...
-
Major changes to the Q-Med board
The nomination committee wants to replace half of the existing board, including the current Chairman. An Extraordinary General Meeting will take place on February 4.
-
Crafoord Prize to an American and two Japanese
Today the Royal Swedish Academy of Sciences announces the laureates of the Crafoord Prize in Polyarthritis 2009.
-
We are poor lobbyists
I doubt there has ever been a really well thought out Scandinavian campaign with intentions to really change attitudes among both the public and politicians.
-
An industry emerging from crisis
"Scanlab is normally indicative of the status of investment incentives in the laboratory industry "
-
Nordisk Produktchef IPSEN
-
Om Life Science Sweden
-
How to get the most out of the fair